Chongsheng Qian
Jiangsu Key Laboratory Of Hematologic Diseases
Suzhou, China
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions.
Journal: Annals of hematology
Published: August 19, 2025
The Application of Personalized Conditioning Regimens in Relapsed/Refractory Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation proceedings
Published: March 04, 2025
The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapy.
Journal: British journal of haematology
Published: January 29, 2025
Corrigendum to "The Use of SARS-CoV-2-Positive Donors in Hematopoietic Stem Cell Transplantation" [Transplant Proc, 2023. 55(8): p. 1810-1814.].
Journal: Transplantation proceedings
Published: November 03, 2024
The Use of SARS-CoV-2-Positive Donors in Hematopoietic Stem Cell Transplantation.
Journal: Transplantation proceedings
Published: April 01, 2023
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia.
Journal: Annals of hematology
Published: September 15, 2022
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 12, 2022
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Journal: Journal of hematology & oncology
Published: February 06, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026